NCT06276491 2026-03-17
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Phase 1 Recruiting
Xencor, Inc.
SWOG Cancer Research Network
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Loma Linda University